Effect of adjuvant therapy with butyric acid on the safety profile of oral antibiotic therapy: a meta-analysis of controlled studies
| Autor: | Dentistry named after A.I. Evdokimov, Moscow, Russia, Dmitrii N. Andreev, Yury A. Kucheryavyy, Igor V. Maev, Aleksandr N. Kaziulin |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Consilium Medicum. 23:402-406 |
| ISSN: | 2542-2170 2075-1753 |
| Popis: | Aim. Systematization of data on the effect of adjuvant therapy with butyric acid (BA) on the safety profile of oral antibiotic therapy (ABT). Methods. Search of studies were carried out in MEDLINE/PubMed, EMBASE, Cochrane, Google Scholar, Russian Science Citation Index (RSCI) electronic databases until April 2021 inclusive. We analyzed titles and annotations in the named databases. The following combination of keywords was used for the search: "butyric acid" or "butyrate" + "antibiotic therapy" or "antibiotics" or "eradication" or "eradication therapy", as well as their analogs in English for searching in foreign databases. Results. The meta-analysis included 9 controlled studies (1 – Italy, 8 – Russia) involving 1409 patients (700 – in groups with BA; 709 – in comparison groups). Meta-analysis showed that the addition of BA to ABT regimens contributes to a significant reduction in the overall incidence of gastrointestinal side effects (odds ratio – OR 0.424, 95% confidence interval – CI 0.218–0.824), the incidence of diarrhea during the 1st (OR 0.228 , 95% CI 0.103–0.507) and 2nd week (OR 0.141, 95% CI 0.0732–0.271), abdominal distention during 1st (OR 0.392, 95% CI 0.180–0.854) and 2nd week ( OR 0.136, 95% CI 0.0480–0.384), bitterness in the mouth during 2nd week (OR 0.284, 95% CI 0.115–0.700). Conclusion. A meta-analysis has shown that the inclusion of BA in ABT regimens significantly reduces the incidence of side effects (diarrhea, bloating, bitterness in the mouth). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|